Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Trajan Group Holdings Ltd ( (AU:TRJ) ) just unveiled an update.
Trajan Group Holdings has reaffirmed its full-year FY26 guidance despite a softer first quarter that weighed on half-year earnings, reporting expected group net revenue growth of 3.8% to $84.1 million for the first half and a decline in normalised EBITDA to $5.0 million, impacted by FX-related asset revaluations, higher freight and timing effects from US tariff recoveries. Management highlighted a sharp improvement in the second quarter, with record quarterly revenue of $45.4 million, a $2.8 million uplift in the capital equipment order book to $10.8 million, and Q2 nEBITDA of $4.5 million, and said recent cost-cutting under Project Neptune and January price increases should support margin expansion and underpin guidance for FY26 net revenue above $170 million and nEBITDA above $16 million, as the resilient components and consumables business offsets volatility in capital equipment.
The most recent analyst rating on (AU:TRJ) stock is a Hold with a A$0.69 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.
More about Trajan Group Holdings Ltd
Trajan Group Holdings Limited is a global analytical science and device company headquartered in Victoria, Australia, specialising in components, consumables and capital equipment for laboratory and analytical applications. Its product portfolio supports analytical workflows across scientific, industrial and healthcare markets, with a growing emphasis on regional manufacturing and supply-chain capabilities to manage tariffs and logistics risks.
Average Trading Volume: 39,834
Technical Sentiment Signal: Sell
Current Market Cap: A$101.4M
For detailed information about TRJ stock, go to TipRanks’ Stock Analysis page.